Filing Details
- Accession Number:
- 0000921895-23-002084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-25 17:36:32
- Reporting Period:
- 2023-08-23
- Accepted Time:
- 2023-08-25 17:36:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
849146 | Lifevantage Corp | LFVN | Pharmaceutical Preparations (2834) | 841097796 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1554334 | Sudbury Capital Fund, Lp | 136 Oak Trail Coppell TX 75019 | No | No | No | Yes | |
1643192 | Judd Dayton | 136 Oak Trail Coppell TX 75019 | No | No | No | Yes | |
1989433 | Sudbury Capital Gp, Lp | 136 Oak Trail Coppell TX 75019 | No | No | No | Yes | |
1989435 | Sudbury Holdings, Llc | 136 Oak Trail Coppell TX 75019 | No | No | No | Yes | |
1989436 | Sudbury Capital Management, Llc | 136 Oak Trail Coppell TX 75019 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-23 | 3,788 | $4.76 | 736,609 | No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
Common Stock | Acquisiton | 2023-08-24 | 7,226 | $4.82 | 743,835 | No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
Common Stock | Acquisiton | 2023-08-25 | 5,490 | $4.95 | 749,325 | No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
No | 4 | P | Indirect | By Sudbury Capital Fund, LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,416 | Direct |
Footnotes
- This Form 4 is filed jointly by Sudbury Capital Fund, LP ("Sudbury Fund"), Sudbury Capital GP, LP ("Sudbury GP"), Sudbury Holdings, LLC ("Sudbury Holdings"), Sudbury Capital Management, LLC ("Sudbury Management") and Dayton Judd (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- Represents securities owned directly by Sudbury Fund. Sudbury GP, as the general partner of Sudbury Fund, may be deemed to beneficially own the securities owned by Sudbury Fund. Sudbury Holdings, as the general partner of Sudbury GP, may be deemed to beneficially own the securities owned by Sudbury Fund. Sudbury Management, as the investment adviser to Sudbury Fund, may be deemed to beneficially own the securities owned by Sudbury Fund. Mr. Judd, as the Sole Member of Sudbury Holdings and Managing Member of Sudbury Management, may be deemed to beneficially own the securities owned by Sudbury Fund.